How many studies have been conducted on Ppar Gamma Agonists?

BiohacksAI has indexed 300 PubMed studies on Ppar Gamma Agonists, including 2 randomized controlled trials (RCTs). 31% of studies involve human subjects.

What are the main research areas for Ppar Gamma Agonists?

The primary research domains for Ppar Gamma Agonists are 🔥 Metabolic, 🔬 Inflammation, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Ppar Gamma Agonists

the insulin action and are used to treat TYPE 2 DIABETES MELLITUS.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 43.6

Research Domains

Ppar Gamma Agonists has been studied across 19 research domains including 🔥 Metabolic, 🔬 Inflammation, 🔬 Oncology, 🧬 Hormones, ❤️ Cardiovascular. The primary research focus is 🔥 Metabolic with 39% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ppar Gamma Agonists is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.